CIK 0001034842 · Accelerated filer
RIGEL PHARMACEUTICALS INC
Sign in to watch- Ticker
- RIGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943248524
- Phone
- 650-624-1100
- Business address
- 611 GATEWAY BOULEVARD, SUITE 900, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- RIGEL PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-28 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2024-02-28 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (right to buy) | +300,000 | 300,000 | ||
| 2024-02-28 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +93,750 | 93,750 | ||
| 2024-02-28 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award · Employee Stock Option (right to buy) | +78,500 | 78,500 | ||
| 2024-02-05 | Santos David A EVP, Chief Commercial Officer | Sale | −8,918 | $1.14 | $10K | 349,093 |
| 2024-02-05 | Schorno Dean L EVP & Chief Financial Officer | Sale | −7,027 | $1.14 | $8K | 402,891 |
| 2024-02-05 | RODRIGUEZ RAUL R CEO, President | Sale | −30,545 | $1.14 | $35K | 2,036,629 |
| 2024-02-02 | Santos David A EVP, Chief Commercial Officer | Sale | −5,601 | $1.13 | $6K | 358,011 |
| 2024-02-02 | Schorno Dean L EVP & Chief Financial Officer | Sale | −5,601 | $1.13 | $6K | 409,918 |
| 2024-02-02 | RODRIGUEZ RAUL R CEO, President | Sale | −22,349 | $1.13 | $25K | 2,067,174 |
| 2024-01-23 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award | +209,000 | 214,000 | ||
| 2024-01-23 | Furey Raymond J. EVP, GC, CCO & Corp Sec | Grant or award · Employee Stock Option (Right to Buy) | +157,000 | 157,000 | ||
| 2024-01-23 | RODRIGUEZ RAUL R CEO, President | Grant or award | +400,000 | 2,089,523 | ||
| 2024-01-23 | RODRIGUEZ RAUL R CEO, President | Grant or award · Employee Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2024-01-23 | Santos David A EVP, Chief Commercial Officer | Grant or award | +209,000 | 363,612 | ||
| 2024-01-23 | Santos David A EVP, Chief Commercial Officer | Grant or award · Employee Stock Option (Right to Buy) | +157,000 | 157,000 | ||
| 2024-01-23 | Schorno Dean L EVP & Chief Financial Officer | Grant or award | +209,000 | 415,519 | ||
| 2024-01-23 | Schorno Dean L EVP & Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +157,000 | 157,000 | ||
| 2023-05-26 | Wasman Jane Director | Grant or award | +25,000 | 75,000 | ||
| 2023-05-26 | Wasman Jane Director | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 |
Page 8 of 9 · 176 trades